Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.13 +0.01 (+0.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Cash & Current Investments (2010 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Cash & Current Investments of $49.77 million for Q2 2026, down 32.1% from $73.32 million a year earlier and unchanged from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Oramed Pharmaceuticals posted Cash & Current Investments of $109.5 million, up 31.6% from FY2024.

  • Cash & Current Investments has increased for four consecutive years, with a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $83.21 million in FY2024 (+24.6%), $66.77 million in FY2023 (+51.0%), $44.21 million in FY2022 (+470.6%) and $7.75 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q2 2023.
  • Year over year, Cash & Current Investments gained in five of the last seven quarters, with growth averaging 15.3%.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 266.2%); the low point was Q2 2023 (a decline of 85.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $49.78 million (Q1 2026), $109.5 million (Q4 2025) and $125.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Oramed Pharmaceuticals 170.52 Mn -164.21 Mn - 49.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.77 Mn
Mar 31, 2026 49.78 Mn
Dec 31, 2025 109.50 Mn
Sep 30, 2025 125.69 Mn
Jun 30, 2025 73.32 Mn
Mar 31, 2025 100.25 Mn
Dec 31, 2024 83.21 Mn
Sep 30, 2024 57.46 Mn
Jun 30, 2024 66.21 Mn
Mar 31, 2024 96.31 Mn
Dec 31, 2023 66.77 Mn
Jun 30, 2023 943,000.00
Mar 31, 2023 2.27 Mn
Dec 31, 2022 44.21 Mn
Sep 30, 2022 5.23 Mn
Jun 30, 2022 6.63 Mn
Mar 31, 2022 7.28 Mn
Nov 30, 2021 39.45 Mn
Aug 31, 2021 83.10 Mn
May 31, 2021 64.62 Mn
API Access

Oramed Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ORMP&period=max&api_key=YOUR_API_KEY